NIH Launches Phase 2 Trial of Biologic in Urban Youth With Type 2 Allergic Asthma - AJMC.com Managed Markets Network

Little data exist on the effectiveness of dupilumab in Black and Hispanic children, even though severe asthma disproportionately affects these populations.

The National Institutes of Health (NIH) said this week it is conducting a double-blind, placebo-controlled, randomized, phase 2 multicenter clinical trial testing whether the biologic dupilumab can r… [+4391 chars]

full article...